Status:
COMPLETED
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
Lead Sponsor:
Centre Hospitalier de Saint-Denis
Conditions:
Alzheimer's Disease
Hippocampus
Eligibility:
All Genders
Brief Summary
This study aims to better understand Alzheimer's disease by looking at brain scans, specifically MRI images, to detect early signs of brain changes linked to the disease. Researchers are focusing on t...
Eligibility Criteria
Inclusion
- Patients who underwent a brain MRI (3D T1 Bravo and Cube FLAIR sequences) between January 2018 and June 2022.
- Diagnosis of Alzheimer's disease (for the Alzheimer group).
- No neurological disease for control group participants.
- Complete clinical and biological assessments available.
- Quality imaging without motion artifacts.
Exclusion
- Incomplete clinical or radiological data.
- Poor image quality (e.g., motion artifacts).
- Presence of other neurodegenerative or psychiatric disorders.
Key Trial Info
Start Date :
November 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 24 2023
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT06965816
Start Date
November 24 2022
End Date
May 24 2023
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
France
Saint-Denis, France